Clinically Important Drug Interactions with Disease-Modifying Antirheumatic Drugs

被引：0
作者：
Cees J. Haagsma
机构：
[1] Medisch Spectrum Twente,Department of Rheumatology
来源：
Drugs & Aging | 1998年 / 13卷
关键词：
Rheumatoid Arthritis; Methotrexate; Cyclosporin; Adis International Limited; Rheumatic Disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Rheumatic diseases are mostly chronic in nature and often require long term drug treatment. An increasing number of disease-modifying antirheumatic drugs (DMARDs) are used earlier in the course of disease and increasingly in combination with each other. Often there is comorbidity with ensuing pharmacotherapy, especially in the elderly, and therefore the risk of unwanted drug interactions increases. Awareness of these interactions is important in order to either avoid or manage them.
引用
收藏
页码：281 / 289
页数：8
相关论文
共 134 条
[1]  
Pincus T(1994)Long-term outcomes in rheumatoid arthritis Br J Rheumatol 34 59-73
[2]  
Borgini MJ(1995)Combination therapy Innovative treatment approaches for rheumatoid arthritis. Ballieres Clin Rheumatol 9 689-710
[3]  
Pualus HE(1996)Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis Clin Pharmacokinet 30 194-210
[4]  
Bannwarth B(1993)Aspirin is not associated with more toxicity than other NSAIDs in patients with RA treated with methotrexate J Rheumatol 20 1297-302
[5]  
Pehourcq F(1994)Do disease-modifying antirheumatic drugs actually modify disease course in rheumatoid arthritis? Clin Immunother 1 319-22
[6]  
Scaeverbeke T(1992)Life table analysis of 879 treatment episodes with slow acting antirheumatic drugs in community rheumatology practice J Rheumatol 19 704-8
[7]  
Rooney RW(1987)Long term treatment of rheumatoid arthritis with suphasalazine, gold, or penicillamine: a comparison using life-table methods Ann Rheum Dis 46 177-83
[8]  
Furst DE(1993)Clinical pharmacokinetics of slow-acting antirheumatic drugs Clin Pharmacokinet 25 392-407
[9]  
Koehnke R(1995)Effects of antirheumatic agents on cytokines Semin Arthritis Rheum 25 234-53
[10]  
Van de Putte PLCM(1994)Chloroquine reduces the bioavailability of methotrexate in patients with rheumatoid arthritis Arthritis Rheum 37 830-3
12345678910